Virulence reduction in bacteriophage resistant bacteria.
about
Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting DiseasesEpigenetic Control of Salmonella enterica O-Antigen Chain Length: A Tradeoff between Virulence and Bacteriophage Resistance.Tripartite species interaction: eukaryotic hosts suffer more from phage susceptible than from phage resistant bacteria.Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa.Analyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus)Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes.Use of bacteriophage to target bacterial surface structures required for virulence: a systematic search for antibiotic alternatives.Genetically modified bacteriophages in applied microbiology.Bacteriophages and its applications: an overview.Microbe-mediated host defence drives the evolution of reduced pathogen virulence.Branched Lateral Tail Fiber Organization in T5-Like Bacteriophages DT57C and DT571/2 is Revealed by Genetic and Functional Analysis.Virus Resistance Is Not Costly in a Marine Alga Evolving under Multiple Environmental Stressors.Mode of resistance to viral lysis affects host growth across multiple environments in the marine picoeukaryote Ostreococcus tauri.Can phage therapy solve the problem of recalcitrant chronic rhinosinusitis?Isolation and characterization of a N4-like lytic bacteriophage infecting Vibrio splendidus, a pathogen of fish and bivalves.Guidelines to Compose an Ideal Bacteriophage Cocktail.Differing responses of red abalone (Haliotis rufescens) and white abalone (H. sorenseni) to infection with phage-associated Candidatus Xenohaliotis californiensis.Identification and Characterization of Type IV Pili as the Cellular Receptor of Broad Host Range Stenotrophomonas maltophilia Bacteriophages DLP1 and DLP2.Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
P2860
Q28069939-47E2530F-3B97-4C00-9375-AB9CEFE21556Q35846135-2C813E3F-67B9-4119-B300-BD8A44E8E63DQ36343614-2ECF641A-D1E8-407E-8165-204F09F48D13Q36812409-1F1A205E-0C90-48D5-9359-A178E05A5E9CQ37173625-D65BA90B-8FF7-48F3-B429-406676CA5198Q37629864-D2CE8DCB-51B1-4130-93E6-59BC22FBB041Q38817547-19AF4EAA-ABC9-4DE9-A156-5184A0BCD738Q38870317-6EF18BC2-E9FA-4591-9555-EBC87C54522CQ38975521-97289373-EFC4-48B4-8547-8EDD78707752Q39187216-A54188E3-26AA-462A-A004-A2CFEC331D92Q40066983-EA1DD254-C8EE-4266-A6B9-4A332760A09CQ40297748-E39B620C-3C66-4DB4-B752-2D85A1951B3BQ40494121-B4D5A94A-8BFB-41D9-9727-8012987EA210Q47899476-C5FF6FA9-DE1D-4F2B-A843-954793FBFF7FQ48336430-E72FDF7B-A146-4C7F-8486-059C3A5B043EQ50100609-DCCC2287-91C4-4927-AFBD-EB8C422C3F7BQ55400792-FCFC0941-33CA-49DC-B9AF-5F8F08C5BD40Q55710360-BC18C6EA-F9FF-48A5-821E-98B93C6029BCQ57940652-580FA4ED-1916-467C-ABE6-F284A3EBBC40
P2860
Virulence reduction in bacteriophage resistant bacteria.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Virulence reduction in bacteriophage resistant bacteria.
@ast
Virulence reduction in bacteriophage resistant bacteria.
@en
type
label
Virulence reduction in bacteriophage resistant bacteria.
@ast
Virulence reduction in bacteriophage resistant bacteria.
@en
prefLabel
Virulence reduction in bacteriophage resistant bacteria.
@ast
Virulence reduction in bacteriophage resistant bacteria.
@en
P2860
P356
P1476
Virulence reduction in bacteriophage resistant bacteria.
@en
P2093
Marcela León
P2860
P356
10.3389/FMICB.2015.00343
P577
2015-04-23T00:00:00Z